Former President, Nucleic Acid Production · MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Andrew Burch

A named executive officer of MARAVAI LIFESCIENCES in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,558,244

Salary $472,583Stock awards $1,901,878Bonus $39,992

FY2023: $2,992,807

2nd of 5 named executive officers at Maravai Lifesciences by FY2024 total.

5 named officers on file for MARAVAI LIFESCIENCES, FY2024

Andrew Burch’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • MRVI’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MARAVAI LIFESCIENCES’s whole pay program stands against its peers

  • MARAVAI LIFESCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRVI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2025 (DEF 14A).

Free

Get Andrew Burch’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Andrew Burch compensation by year

MARAVAI LIFESCIENCES Summary Compensation Table · all 2 fiscal years held
In US dollars, as MARAVAI LIFESCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$371,539$472,583
Bonus$44,462$39,992
Stock awards$1,993,896$1,901,878
Option awards$573,760$0
Non-equity incentive$0$134,641
Pension and deferred compensation$0$0
All other$9,150$9,150
Total$2,992,807$2,558,244

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MARAVAI LIFESCIENCES HOLDINGS, INC. DEF 14A filed April 18, 2025, accession 0001193125-25-085761, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MARAVAI LIFESCIENCES HOLDINGS, INC. filed document, accession 0001193125-25-085761. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2025.

$3.0M
$2.6M
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU295,782$1,612,012—
RSU94,007$512,338—
Option46,667—$14.14

Per the Outstanding Equity Awards at Fiscal Year-End table in MARAVAI LIFESCIENCES HOLDINGS, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Change-in-control & termination

estimated payments MARAVAI LIFESCIENCES discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control and involuntary termination$1,952,010$2,124,350$42,412$4,118,772
Involuntary termination without cause$809,370$0$28,275$837,645

Per the Potential Payments Upon Termination or Change in Control table in MARAVAI LIFESCIENCES HOLDINGS, INC.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

MARAVAI LIFESCIENCES’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
William MartinChief Executive Officer$6,380,399
Andrew Burch · this pageFormer President, Nucleic Acid Production$2,558,244
Rebecca BuzzeoChief Commercial Officer$2,459,680
Peter LeddyChief Administrative Officer$2,363,764
Kevin HerdeChief Financial Officer$2,339,364

The full MARAVAI LIFESCIENCES compensation record

free company brief

This page is one person within MARAVAI LIFESCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MARAVAI LIFESCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MARAVAI LIFESCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Andrew Burch's compensation dossier · One-time report. No refunds.